Bowhead Proxy Supplement Discloses 11 Demand Letters, 2 Suits Seeking to Block $34/Share AmFam Deal
BOW sits 61% above its 52-week low of $21.21.
Summary
Bowhead's supplemental proxy discloses 11 demand letters and two lawsuits seeking to block its $34.00 per share all-cash sale to American Family, and adds new detail on the sale process and Ardea's valuation ranges ahead of the November 13, 2026 shareholder vote.
Key Events · M&A and Partnerships · BOW
-
Proxy Supplement Filed Ahead of Vote
Definitive additional materials supplement the October 14, 2026 definitive proxy for the November 13, 2026 special meeting on the $34.00 per share all-cash merger with American Family.
-
Eleven Demand Letters, Two Suits
As of November 3, 2026 the company has received 11 stockholder demand letters and faces two New York Supreme Court complaints (Dixon, Index No. 656007/2026; Ballard, Index No. 656028/2026) alleging proxy deficiencies and seeking to enjoin the merger.
-
Litigation Could Delay Closing
Bowhead says the claims are meritless but warns unresolved suits could prevent or delay the merger and add substantial cost; a closing condition requires no legal restraint on the deal.
-
Ardea Valuation Ranges Quantified
Ardea's analysis applies 11.1x-21.1x to 2026 EPS of $2.30 ($25.58-$48.57 per share) and 9.5x-22.6x to 2027 EPS of $2.75 ($26.19-$62.14 per share), with Bowhead standalone unaffected at $30.59.
Analysis · BOW · Finance
Bowhead filed supplemental proxy materials after eleven stockholder demand letters and two New York Supreme Court complaints (Dixon and Ballard) alleged the definitive proxy omitted material information and asked the court to enjoin the $34.00 per share all-cash sale to American Family. The company calls the claims meritless but is settling the disclosure record to remove a litigation excuse for delay. The supplement also adds detail on the sale process and Ardea's fairness math: peer P/E ranges of 11.1x-21.1x on 2026 EPS of $2.30 imply $25.58-$48.57 per share, and 9.5x-22.6x on 2027 EPS of $2.75 imply $26.19-$62.14, framing $34.00 as inside the range. With the special meeting set for November 13, 2026, the practical risk is that an injunction, not the vote, decides timing; a condition to closing is that no legal restraint be in effect.
How filings like this one have moved
In the 30 days to Nov 4, 2026, 32.4% of the 2221 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BOW was trading at $34.16 on NYSE in the Finance sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $21.21 to $35.07. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.